Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG - World Stem Cell Summit

World Stem Cell Summit to feature Special Symposium on the Intersection of Regenerative Medicine and Healthspan – June 5-9

by admin | Apr 12, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

The 20th World Stem Cell Summit (WSCS), in association with the Healthspan Action Coalition, announced that it will showcase a Special Symposium and Focus Sessions on the “Intersection of Regenerative Medicine and Healthspan” – focusing on the...

Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells

by admin | Apr 11, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Ingrid Wickelgren – Scientific American This novel injection system could help advance gene therapy by nimbly inserting gene-editing enzymes into a variety of cell types nside the gut of a caterpillar lives a worm, and inside the worm lurks a bioluminescent...

New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnology

by admin | Apr 10, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Okinawa Institute of Science and Technology Turning genes on and off as easily and predictably as flicking a switch could be a powerful tool in medicine and biotech. A type of technology called a riboswitch might be the key. The Okinawa Institute of Science and...

Veterans Affairs to Be First Major Insurer to Cover Alzheimer’s Drug Leqembi

by admin | Apr 7, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Roughly 168,000 veterans receiving care have Alzheimer’s dementia By Joseph Walker – The Wall Street journal Eisai Co.’s new Alzheimer’s disease drug Leqembi will be covered by the U.S. Department of Veterans Affairs, the first major insurer to agree to pay for...

Silicon Valley Bank failure spooks digital health, biotech industries

by admin | Apr 6, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Tina Reed – Axios Digital health and biotech firms made up a substantial part of Silicon Valley Bank’s client base. And its historic failure is raising troubling questions about how much the fallout will hurt emerging health companies in need of...

Athenex’s cash dries up as it faces clinical hold on cancer therapy in wake of patient death

by admin | Mar 31, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Gabrielle Masson – Fierce Biotech News Athenex is in a tight spot, trying to stretch out its remaining cash and ward off an unruly creditor just as the FDA slaps a clinical hold on its neuroblastoma cell therapy while it explores a patient’s death in a...